Pharmafile Logo

The driving force behind Momentum Strategy

An internet search on what makes a business successful delivers countless promises to reveal the secrets behind sustained growth. The strategies of well-known companies provide valuable case studies that have helped us identify the key factors that enable businesses to prosper. Using examples from outside pharma, Lucid’s newly launched Strategic Consultancy has recognised three key spheres that generate exceptional growth in the pharma industry: discover, value and enable. This new commercial approach is called Momentum Strategy.

In the April issue of PME magazine, Lucid Strategic Consultancy gives further insight into the three key spheres of Momentum Strategy. The discover sphere is focused on generating compelling insights to prioritise delivering commercial value (inspired by Under Armour). The value sphere allows us to capture compelling value and translate this into a differentiated and sustainable customer experience (inspired by Innocent). The enable sphere provides compelling engagement and innovative initiatives across teams (inspired by giffgaff). With this new dynamic approach, Lucid Strategic Consultancy aims to provide a comprehensive solution to the product life-cycle management.

To find out more about the Lucid Strategic Consultancy, please contact Duncan Ferguson (+44 (0)1494 755707, duncan@lucid-group.co.uk) or visit www.lucid-group.co.uk/strategic-consultancy

You can access the full article here: http://media.wix.com/ugd/b62ab8_4f835e74f2524936a053803097f2fd26.pdf

- PMLiVE

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

My Lucid journey from PMW to Head of Medical

Working in Medical Communications has never been about the nine to five. Fusing science and language in the service of both clients and patients, this is typically a fast paced...

Listen, learn and lift off

In April’s PME, Danny Buckland has been talking to industry leaders about launch excellence in the featured article, Listen, learn and lift off.Buckland points out that pandemic storms have changed the...

Launch excellence

In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines...

Meet The Lucid Group Talent Team

Meet our talent team, they're here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your...

Extraordinary lives: advancing change in rare diseases (Part 2)

In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

Extraordinary lives: advancing change in rare diseases (Part 2)

In support of Rare Disease Day, we're excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

Extraordinary lives: advancing change in rare diseases (Part 1)

Rare Disease Day is all about raising awareness and generating change for the 300 million people worldwide living with a rare disease. The global rare disease community and its supporters come together on...

My Journey into MedComms #LucidLife

I began as a medical writer after almost a decade working in medical publishing as a production editor. Whilst working in publishing, I was exposed to lots of different writing...

International Women’s Day 2022 #BreakTheBias

Today is International Women’s Day. This day is about gender equality, which, to be achieved, must involve the calling out of gender bias, discrimination and stereotyping.Individually, we're all responsible for...